Asia-Pacific Opioids Market Report 2017

July 2017 | 103 pages | ID: A46E87A56E5EN
QYResearch

Abstracts

In this report, the Asia-Pacific Opioids market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Opioids for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Opioids market competition by top manufacturers/players, with Opioids sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer Inc
• Purdue Pharma
• Boehringer Ingelheim
• Janssen Pharmaceuticals
• Actavis Plc
• Sanofi
• Sun Pharmaceutical Industries Ltd
• Mallinckrodt Pharmaceuticals
• Endo Pharmaceuticals Inc
• Egalet

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Morphine
• Codeine
• Methadone
• Meperidine
• Fentanyl

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Opioids for each application, includin

• Anesthesia
• Cough Suppressant
• Diarrhea suppressant

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Opioids Market Report 2017

1 OPIOIDS OVERVIEW

1.1 Product Overview and Scope of Opioids
1.2 Classification of Opioids by Product Category
  1.2.1 Asia-Pacific Opioids Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Opioids Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Morphine
  1.2.4 Codeine
  1.2.5 Methadone
  1.2.6 Meperidine
  1.2.7 Fentanyl
1.3 Asia-Pacific Opioids Market by Application/End Users
  1.3.1 Asia-Pacific Opioids Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Anesthesia
  1.3.3 Cough Suppressant
  1.3.4 Diarrhea suppressant
1.4 Asia-Pacific Opioids Market by Region
  1.4.1 Asia-Pacific Opioids Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Opioids (2012-2022)
  1.5.1 Asia-Pacific Opioids Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Opioids Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC OPIOIDS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Opioids Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Opioids Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Opioids Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Opioids (Volume and Value) by Type
  2.2.1 Asia-Pacific Opioids Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Opioids Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Opioids (Volume) by Application
2.4 Asia-Pacific Opioids (Volume and Value) by Region
  2.4.1 Asia-Pacific Opioids Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Opioids Revenue and Market Share by Region (2012-2017)

3 CHINA OPIOIDS (VOLUME, VALUE AND SALES PRICE)

3.1 China Opioids Sales and Value (2012-2017)
  3.1.1 China Opioids Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Opioids Revenue and Growth Rate (2012-2017)
  3.1.3 China Opioids Sales Price Trend (2012-2017)
3.2 China Opioids Sales Volume and Market Share by Type
3.3 China Opioids Sales Volume and Market Share by Application

4 JAPAN OPIOIDS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Opioids Sales and Value (2012-2017)
  4.1.1 Japan Opioids Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Opioids Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Opioids Sales Price Trend (2012-2017)
4.2 Japan Opioids Sales Volume and Market Share by Type
4.3 Japan Opioids Sales Volume and Market Share by Application

5 SOUTH KOREA OPIOIDS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Opioids Sales and Value (2012-2017)
  5.1.1 South Korea Opioids Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Opioids Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Opioids Sales Price Trend (2012-2017)
5.2 South Korea Opioids Sales Volume and Market Share by Type
5.3 South Korea Opioids Sales Volume and Market Share by Application

6 TAIWAN OPIOIDS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Opioids Sales and Value (2012-2017)
  6.1.1 Taiwan Opioids Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Opioids Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Opioids Sales Price Trend (2012-2017)
6.2 Taiwan Opioids Sales Volume and Market Share by Type
6.3 Taiwan Opioids Sales Volume and Market Share by Application

7 INDIA OPIOIDS (VOLUME, VALUE AND SALES PRICE)

7.1 India Opioids Sales and Value (2012-2017)
  7.1.1 India Opioids Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Opioids Revenue and Growth Rate (2012-2017)
  7.1.3 India Opioids Sales Price Trend (2012-2017)
7.2 India Opioids Sales Volume and Market Share by Type
7.3 India Opioids Sales Volume and Market Share by Application

8 SOUTHEAST ASIA OPIOIDS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Opioids Sales and Value (2012-2017)
  8.1.1 Southeast Asia Opioids Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Opioids Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Opioids Sales Price Trend (2012-2017)
8.2 Southeast Asia Opioids Sales Volume and Market Share by Type
8.3 Southeast Asia Opioids Sales Volume and Market Share by Application

9 AUSTRALIA OPIOIDS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Opioids Sales and Value (2012-2017)
  9.1.1 Australia Opioids Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Opioids Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Opioids Sales Price Trend (2012-2017)
9.2 Australia Opioids Sales Volume and Market Share by Type
9.3 Australia Opioids Sales Volume and Market Share by Application

10 ASIA-PACIFIC OPIOIDS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Pfizer Inc
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Opioids Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Pfizer Inc Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Purdue Pharma
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Opioids Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Purdue Pharma Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Boehringer Ingelheim
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Opioids Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Boehringer Ingelheim Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Janssen Pharmaceuticals
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Opioids Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Janssen Pharmaceuticals Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Actavis Plc
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Opioids Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Actavis Plc Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Sanofi
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Opioids Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Sanofi Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Sun Pharmaceutical Industries Ltd
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Opioids Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Sun Pharmaceutical Industries Ltd Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Mallinckrodt Pharmaceuticals
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Opioids Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Mallinckrodt Pharmaceuticals Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Endo Pharmaceuticals Inc
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Opioids Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Endo Pharmaceuticals Inc Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Egalet
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Opioids Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Egalet Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 OPIOIDS MANUFACTURING COST ANALYSIS

11.1 Opioids Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Opioids

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Opioids Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Opioids Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC OPIOIDS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Opioids Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Opioids Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Opioids Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Opioids Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Opioids Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Opioids Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Opioids Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Opioids Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Opioids Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Opioids Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Opioids Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Opioids Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Opioids Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Opioids Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Opioids Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Opioids Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Opioids Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Opioids Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Opioids Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Opioids
Figure Asia-Pacific Opioids Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Opioids Sales Volume Market Share by Type (Product Category) in 2016
Figure Morphine Product Picture
Figure Codeine Product Picture
Figure Methadone Product Picture
Figure Meperidine Product Picture
Figure Fentanyl Product Picture
Figure Asia-Pacific Opioids Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Opioids by Application in 2016
Figure Anesthesia Examples
Table Key Downstream Customer in Anesthesia
Figure Cough Suppressant Examples
Table Key Downstream Customer in Cough Suppressant
Figure Diarrhea suppressant Examples
Table Key Downstream Customer in Diarrhea suppressant
Figure Asia-Pacific Opioids Market Size (Million USD) by Region (2012-2022)
Figure China Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Opioids Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Opioids Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Opioids Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Opioids Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Opioids Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Opioids Sales Share by Players/Suppliers
Figure Asia-Pacific Opioids Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Opioids Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Opioids Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Opioids Revenue Share by Players
Figure 2017 Asia-Pacific Opioids Revenue Share by Players
Table Asia-Pacific Opioids Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Opioids Sales Share by Type (2012-2017)
Figure Sales Market Share of Opioids by Type (2012-2017)
Figure Asia-Pacific Opioids Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Opioids Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Opioids Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Opioids by Type (2012-2017)
Figure Asia-Pacific Opioids Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Opioids Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Opioids Sales Share by Region (2012-2017)
Figure Sales Market Share of Opioids by Region (2012-2017)
Figure Asia-Pacific Opioids Sales Market Share by Region in 2016
Table Asia-Pacific Opioids Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Opioids Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Opioids by Region (2012-2017)
Figure Asia-Pacific Opioids Revenue Market Share by Region in 2016
Table Asia-Pacific Opioids Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Opioids Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Opioids Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Opioids Sales Market Share by Application (2012-2017)
Figure China Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure China Opioids Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Opioids Sales Price (USD/Unit) Trend (2012-2017)
Table China Opioids Sales Volume (K Units) by Type (2012-2017)
Table China Opioids Sales Volume Market Share by Type (2012-2017)
Figure China Opioids Sales Volume Market Share by Type in 2016
Table China Opioids Sales Volume (K Units) by Applications (2012-2017)
Table China Opioids Sales Volume Market Share by Application (2012-2017)
Figure China Opioids Sales Volume Market Share by Application in 2016
Figure Japan Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Opioids Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Opioids Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Opioids Sales Volume (K Units) by Type (2012-2017)
Table Japan Opioids Sales Volume Market Share by Type (2012-2017)
Figure Japan Opioids Sales Volume Market Share by Type in 2016
Table Japan Opioids Sales Volume (K Units) by Applications (2012-2017)
Table Japan Opioids Sales Volume Market Share by Application (2012-2017)
Figure Japan Opioids Sales Volume Market Share by Application in 2016
Figure South Korea Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Opioids Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Opioids Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Opioids Sales Volume (K Units) by Type (2012-2017)
Table South Korea Opioids Sales Volume Market Share by Type (2012-2017)
Figure South Korea Opioids Sales Volume Market Share by Type in 2016
Table South Korea Opioids Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Opioids Sales Volume Market Share by Application (2012-2017)
Figure South Korea Opioids Sales Volume Market Share by Application in 2016
Figure Taiwan Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Opioids Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Opioids Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Opioids Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Opioids Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Opioids Sales Volume Market Share by Type in 2016
Table Taiwan Opioids Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Opioids Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Opioids Sales Volume Market Share by Application in 2016
Figure India Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure India Opioids Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Opioids Sales Price (USD/Unit) Trend (2012-2017)
Table India Opioids Sales Volume (K Units) by Type (2012-2017)
Table India Opioids Sales Volume Market Share by Type (2012-2017)
Figure India Opioids Sales Volume Market Share by Type in 2016
Table India Opioids Sales Volume (K Units) by Application (2012-2017)
Table India Opioids Sales Volume Market Share by Application (2012-2017)
Figure India Opioids Sales Volume Market Share by Application in 2016
Figure Southeast Asia Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Opioids Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Opioids Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Opioids Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Opioids Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Opioids Sales Volume Market Share by Type in 2016
Table Southeast Asia Opioids Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Opioids Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Opioids Sales Volume Market Share by Application in 2016
Figure Australia Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Opioids Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Opioids Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Opioids Sales Volume (K Units) by Type (2012-2017)
Table Australia Opioids Sales Volume Market Share by Type (2012-2017)
Figure Australia Opioids Sales Volume Market Share by Type in 2016
Table Australia Opioids Sales Volume (K Units) by Applications (2012-2017)
Table Australia Opioids Sales Volume Market Share by Application (2012-2017)
Figure Australia Opioids Sales Volume Market Share by Application in 2016
Table Pfizer Inc Opioids Basic Information List
Table Pfizer Inc Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Inc Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Inc Opioids Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Inc Opioids Revenue Market Share in Asia-Pacific (2012-2017)
Table Purdue Pharma Opioids Basic Information List
Table Purdue Pharma Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Purdue Pharma Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Purdue Pharma Opioids Sales Market Share in Asia-Pacific (2012-2017)
Figure Purdue Pharma Opioids Revenue Market Share in Asia-Pacific (2012-2017)
Table Boehringer Ingelheim Opioids Basic Information List
Table Boehringer Ingelheim Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim Opioids Sales Market Share in Asia-Pacific (2012-2017)
Figure Boehringer Ingelheim Opioids Revenue Market Share in Asia-Pacific (2012-2017)
Table Janssen Pharmaceuticals Opioids Basic Information List
Table Janssen Pharmaceuticals Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Janssen Pharmaceuticals Opioids Sales Market Share in Asia-Pacific (2012-2017)
Figure Janssen Pharmaceuticals Opioids Revenue Market Share in Asia-Pacific (2012-2017)
Table Actavis Plc Opioids Basic Information List
Table Actavis Plc Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actavis Plc Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Actavis Plc Opioids Sales Market Share in Asia-Pacific (2012-2017)
Figure Actavis Plc Opioids Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi Opioids Basic Information List
Table Sanofi Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Opioids Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi Opioids Revenue Market Share in Asia-Pacific (2012-2017)
Table Sun Pharmaceutical Industries Ltd Opioids Basic Information List
Table Sun Pharmaceutical Industries Ltd Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industries Ltd Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industries Ltd Opioids Sales Market Share in Asia-Pacific (2012-2017)
Figure Sun Pharmaceutical Industries Ltd Opioids Revenue Market Share in Asia-Pacific (2012-2017)
Table Mallinckrodt Pharmaceuticals Opioids Basic Information List
Table Mallinckrodt Pharmaceuticals Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mallinckrodt Pharmaceuticals Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Mallinckrodt Pharmaceuticals Opioids Sales Market Share in Asia-Pacific (2012-2017)
Figure Mallinckrodt Pharmaceuticals Opioids Revenue Market Share in Asia-Pacific (2012-2017)
Table Endo Pharmaceuticals Inc Opioids Basic Information List
Table Endo Pharmaceuticals Inc Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Endo Pharmaceuticals Inc Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Endo Pharmaceuticals Inc Opioids Sales Market Share in Asia-Pacific (2012-2017)
Figure Endo Pharmaceuticals Inc Opioids Revenue Market Share in Asia-Pacific (2012-2017)
Table Egalet Opioids Basic Information List
Table Egalet Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Egalet Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Egalet Opioids Sales Market Share in Asia-Pacific (2012-2017)
Figure Egalet Opioids Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioids
Figure Manufacturing Process Analysis of Opioids
Figure Opioids Industrial Chain Analysis
Table Raw Materials Sources of Opioids Major Manufacturers in 2016
Table Major Buyers of Opioids
Table Distributors/Traders List
Figure Asia-Pacific Opioids Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Opioids Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Opioids Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Opioids Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Opioids Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Opioids Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Opioids Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Opioids Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Opioids Revenue Market Share Forecast by Region in 2022
Figure China Opioids Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Opioids Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Opioids Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Opioids Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Opioids Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Opioids Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Opioids Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Opioids Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Opioids Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Opioids Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Opioids Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Opioids Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Opioids Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Opioids Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Opioids Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Opioids Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Opioids Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Opioids Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Opioids Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Opioids Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Opioids Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources